Selectively inhibits protein kinase C (PKC)-induced activation of the NF-kappaB pathway (IC50 < 0.1um for PMA-stimulated IL-8 production). Inhibits antigen receptor-stimulated NF-kappaB activation in chronic lymphocytic leukemia (CLL) B cells. Does not inhibit other NF-kappaB pathways, including that activated by tumor necrosis factor (TNF). Sequence: C28H39N3O3 Solubility: DMSO (~20mM), Ethanol (~20mM) Molecular Weight: ~465.63 Storage and Stability: Lyophilized powder may be stored at -20C. Stable for 12 months at -20C. Reconstitute with sterile ddH2O. Aliquot to avoid repeated freezing and thawing. Store at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
Molecular Weight:
465.63
Purity:
~98% (HPLC)
Form:
Supplied as a pale yellow solid.
CAS Number:
[758679-97-9]
* VAT and and shipping costs not included. Errors and price changes excepted